In patient 1, serum AFP, which is known to increase not only during development of hepatocellular carcinoma but also liver regeneration, modestly increased during the rh-HGF dosing period, followed by a gradual decrease during the observation period. Here, AFP is linked to hepatocellular carcinoma.